Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.
The Sputnik Light vaccine, like Sputnik V, is based on a proven well-studied human adenovirus vector platform; these vectors cause the common cold and have peacefully coexisted with humanity for millenia.
Safety of Sputnik Light, as the first component of Sputnik V, was confirmed by real-world data from UAE, Bahrain, Argentina, Russia, Mexico, Serbia, San Marino, Philippines, Libya, Paraguay, Hungary, Azerbaijan and Belarus.
proven efficacy against infection,higher than that of most two-shot vaccines
The efficacy against hospitalization and severe disease is even higher
Sputnik Light is also a leading booster shot
Sputnik Light as a stand-alone vaccine is highly effective against Delta and other mutations
efficacy against infection by Delta
efficacy in the age group below 60
higher than that of most two-shot vaccines
Sputnik Light efficacy as a booster will be close to that of two shots of Sputnik V against Delta
effective against infection
effective against hospitalization
Sputnik Light has a long-lasting protection, which even increases over 4-6 months following the vaccination.
Many other vaccines showed dramatic decrease in efficacy against Delta variant to below 50% within the same time period.
Sputnik Light safety was confirmed by real-world data from multiple countries and by over 20 publications in the leading international scientific journals.
Sputnik Light, the first component of Sputnik V, became a significant part of immunization programme in Argentina
Source: JHU CSSE COVID-19 Data
Phase I/II of the Safety and Immunogenicity Study of the Sputnik Light vaccine has demonstrated that:
Ministry of Health Registration Certificate
Message has been successfully sent!